Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

1996 Abstracts/Presentations

  1. Ames, M.M., Walker, D.K., Reid, J.M., Svingen, P.A., Budihardjo, I., Kaufmann, S.H., Covey, J.M., Alley, M.C., Hollingshead, M.G., 1996. 6-Aminonicotinamide: Murine Plasma Pharmacokinetics and Modulation of Drug Resistance. [Abstract No. 1965]. Proc. Amer. Assoc. Cancer Res., 37, 289.
  2. Bigelow, J., Chrin, L., Mathews, L., McCormack, J., 1996. Analytical and pharmacokinetic studies with a novel tetrameric phosphorothioate oligodeoxynucleotide. [Abstract No. 2418]. Proc. Amer. Assoc. Cancer Res., 37, 354.
  3. Bigelow, J., Chrin, L., Mathews, L., McCormack, J., 1996. Analytical and pharmacokinetics studies with two complex naphthalenesulfonic acid derivatives. [Abstract No. 2536]. Proc. Amer. Assoc. Cancer Res., 37, 372.
  4. Chan, K.K., Bakhtiar, R., Jiang, C., 1996. Depsipeptide (NSC-630176) pharmacokinetics in the rat by LC/MS/MS. [Abstract No. 2711]. Proc. Amer. Assoc. Cancer Res., 37, 397.
  5. Chiu, M., Chan, K.K., Covey, J.M., Tosca, P.J., Placke, M.E., Tomaszewski, J.E., 1996. Preclinical Pharmacokinetics of the Anti-HIV Agent, Michellamine B (NSC-661755). [Abstract No. 2517]. Proc. Amer. Assoc. Cancer Res., 37, 42.
  6. Egorin, M.J., Eiseman, J.K., Sentz, D.L., Rosen, D.M., Ballesteros, M.F., Kearns, C.M., Duncan, K., Callery, P., 1996. Pharmacokinetics (PK) & Tissue Distribution of Halomon in CD2F1 Mice. [Abstract No. 2544]. Proc. Amer. Assoc. Cancer Res., 37, 373.
  7. Eiseman, J.L., Eddington, N.D., Sentz, D.L., Rosen, D.M., Ballesteros, M.F., Egorin, M.J., 1996. Tissue Distribution and Physiological Model of Halomon in Male and Female CD2F1 Mice. [Abstract No. 2543]. Proc. Amer. Assoc. Cancer Res., 37, 373.
  8. Hill, D.L., Rose, L.M., Tillery, K., Lin, T.H., 1996. Use of HPLC for Determination of Pharmacokinetics of SarCNU (NSC-364432) in Rat Plasma. [Abstract No. 2503]. Proc. Amer. Assoc. Cancer Res., 37, 367.
  9. Levine, B.S., Wheeler, C.W., Tomaszewski, J.E., Morrissey, R.L., Schweikart, K.M., Tosca, P.J., Singer, A.J. and Donohue, S.J., 1996. Preclinical Toxicology Studies of SarCNU. [Abstract No. 2554]. Proc. Amer. Assoc. Cancer Res., 37, 42.
  10. Mirsalis, J.C., Schindler-Horvat, J.E., Tomaszewski J.E., Fairchild, D.G., Hill, J.R., Tyson, C.A., Schweikart, K.M., Turner, N.A., Sells, D., Donohue, S.J., 1996. Preclinical Toxicology Studies of Ecteinascidin 743. [Abstract No. 2556]. Proc. Amer. Assoc. Cancer Res., 37, 42.
  11. Newman, R.A., Chen, W., Madden, T., 1996. Preclinical Pharmacology and Pharmacokinetics of the Calanolides, a Novel Series of Non-nucleoside Anti-HIV Compounds. [Abstract No. 2787]. Proc. Amer. Assoc. Cancer Res., 37, 408.
  12. Page, J.G., Rodman, L.E., Heath, J.E., Tomaszewski, J.E., Smith, A.C., 1996. Comparison of the Toxicity of Depsipeptide (NSC-630176) in Dogs and Rats.[Abstract No. 2549]. Proc. Amer. Assoc. Cancer Res., 37, 42.
  13. Rajgolikar, G., Wang, H.-C.R., Chan, K.K., 1996. Cytotoxicity of Depsipeptide (NSC-630176, FR901288) in scr-Transformed 10T1/2 Cells. [Abstract No. 2712]. Proc. Amer. Assoc. Cancer Res., 37, 397.
  14. Rodman, L.E., Giles, H.D., Farnell, D.R., Hill, D.L., Coyne, J.M., Tomaszewski, J.E., Smith, A.C., Page, J.G., 1996. Preclinical Toxicology Studies of Cordycepin (NSC-63984) in Combination with 2'-Deoxycoformycin (NSC-218321) in Beagle Dogs. [Abstract No. 2550]. Proc. Amer. Assoc. Cancer Res., 37, 42.
  15. Rosen, D.M., Benjamin, S.E., Eiseman, J.L., Sentz, D.L., Callery, P.S., Anderson, L.W., Strong, J.M., Duncan, K.L.K., Egorin, M.J., 1996. In Vitro Metabolism of Halomon by Mouse and Human Liver Preparations. [Abstract No. 2730]. Proc. Amer. Assoc. Cancer Res., 37, 400.
  16. Schweikart, K.M., Sullivan, T.M., Shaw, M.E., Walters, D.L., Placke, M.E., Tabibi, E., Tomaszewski, J.E., 1996. Bioequivalence of Nanodispersed (Cremophor-free) vs. Cremophor-containing Formulations of Paclitaxel in Beagle Dogs. [Abstract No. 2502]. Proc. Amer. Assoc. Cancer Res., 37, 211.
  17. Shostak, L., McCormack, J., Zon, G., 1996. Interactions of Phosphorothioate Oligodeoxynucleotides with DNA Binding Agents. [Abstract No. 2417]. Proc. Amer. Assoc. Cancer Res., 37, 354.
  18. Smith, A.C., Rodman, L.E., Heath, J.E., Kovatch, R.A., Tomaszewski, J.E., Phillips, L.R., Wolfe, T.L., Supko, J.G., Page, J.G., 1996. Toxicity Produced by Breflate (NSC-656202), a Brefeldin a Prodrug, in Fischer 344 Rats and Beagle Dogs. [Abstract No. 2548]. Proc. Amer. Assoc. Cancer Res., 37, 42.
  19. Green, C.E., Muir, C., Romero, M., Tyson, C.A., Donohue, S.J., Tomaszewski, J.E., 1996. Pharmacokinetics of Quinocarmycin Analog DX-52-1 (NSC 607097) in Male Fischer 344 Rats. ISSX Proc., 10, 283.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director, collinsje@mail.nih.gov